… approached distinctive causes of heart failure in both humans … of novel targets for heart failure
prevention and therapy. In this … its therapeutic potential against cardiac oxidative damage. …

… Anemia has recently been recognized as an important comorbid condition and potentially
novel therapeutic target in patients with heart failure (HF). Anemia is common in HF patients, …

… Many authors have studied the cardiovascular effects of CBD to explore its therapeutic
potential in a variety of cardiomyopathies, from healing injury caused by several cell stressors to …

… Outcomes of several ongoing prospective studies of SGLT‐2 inhibitors in HF (Figure 3) are
needed to fully evaluate the therapeutic potential of SGLT‐2 inhibitors in HF, with and without …

… The therapeutic potential of SERCA2a gene transfer to failing myocardial tissue has also …
The therapeutic potential of SERCA2a gene delivery has also been recently addressed in a …

… To determine the therapeutic potential of miR-208a inhibition in cardiomyocytes in vivo, we
designed an LNA-containing anti-miR targeting bases 2 to 17 of the 5′ region of mature miR…

… Despite great advances in the understanding and treatment of heart failure (HF), the disease
remains a leading cause of death worldwide. As patients with advanced HF outnumber …

… Excess interstitial fibrosis is an important detrimental aspect of chronic LVH and chronic
heart failure (CHF). Oxidative stress is well known to be pro-fibrotic in many organs, and recent …

The apelin receptor was initially classed as an orphan G-protein-coupled receptor, and little
was known about its physiological functions until apelin, the endogenous ligand, was …

… Heart failure is a pressing worldwide public-health problem with millions of patients having
worsening heart failure. … given that most patients with heart failure have viable dysfunctional …